2023年2月9日 · Chemo brain is a common term used by cancer survivors to describe thinking and memory problems that can occur during and after cancer treatment. Chemo brain can also be called chemo fog, cancer-related cognitive impairment or cognitive dysfunction.

Some people with cancer notice that they can’t think as clearly as they used to. They may have trouble remembering things, focusing, finishing tasks, or learning something new. These are symptoms of cognitive impairment, also known as “chemo brain” or “brain fog.” Memory, thinking, and focus changes typically go away over time.

Timely and important review on chemobrain, from the existing consensus to new potential mechanisms based on Alzheimer's disease or traumatic brain injury pathologies, suggesting chemobrain as a persistent neurological disorder.

Chemobrain is a symptom reported by many cancer patients with difficulty processing information. It is a legitimate, diagnosable condition that can be caused by chemotherapy treatment, the cancer itself, or secondary medical conditions such as anemia.

2022年1月1日 · Chemo-brain refers to the thinking and memory problems that occur in cancer patients during and after chemotherapy. It is also known as cognitive dysfunction or chemo-fog. Risk factors include brain malignancies, either primary or metastatic, radiotherapy and chemotherapy, either systemic or brain targeted.

2017年3月1日 · Research confirms that chemobrain is a real side effect of cancer treatment. In this Q&A, Jeffrey Wefel, Ph.D., answers the biggest questions patients have about chemobrain during and after cancer treatment.

Nowadays, chemotherapy-induced cognitive impairment or 'chemobrain' is a well-established clinical syndrome, consisting of moderate to subtle cognitive changes across various domains, especially working memory, executive function and episodic verbal memory that persist only in a subgroup of long-ter …

2020年6月8日 · We start by outlining why the post-mitotic adult brain is particularly vulnerable to chemotherapy. Next, through drawing comparisons with normal aging, Alzheimer's disease, and traumatic brain injury, we identify universal cellular mechanisms that may underlie the cognitive deficits in chemobrain.

Chemotherapy-induced cognitive impairment or chemobrain is a frequent consequence of cancer treatment with many psychiatric features. Ironically, the increasing efficacy of chemotherapy leaves growing number of patients alive with chemobrain.

Chemobrain, a well-established clinical syndrome, has become an increasing concern because the number of long-term cancer survivors is growing dramatically. There is strong evidence that correlates changes in peripheral cytokines with the development of chemobrain in commonly used chemotherapeutic drugs for different types of cancer.